EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application

Meaghan Polack, Gabi W van Pelt, Augustinus S L P Crobach, Lioe-Fee de Geus-Oei, Rob A E M Tollenaar, J Han J M van Krieken, Wilma E Mesker

Cancer Treatment and Research Communications · 2025

DOI: 10.1016/j.ctarc.2025.100964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Meaghan Polack und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Serine Endopeptidases, Gelatinases, Membrane Proteins. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer is highly prevalent. The stromal tumour microenvironment significantly influences tumour behaviour, and cancer-associated fibroblasts (CAFs), as major component of tumour stroma, are increasingly studied. Specifically, CAF-marker fibroblast activation protein (FAP) is gaining interest as tracer for imaging using radiolabelled FAP-inhibitor (FAPI). We describe patterns of FAP-expression, and associations to intratumoural stroma amount, establishing a biological background and potential future reference to pathology assessment. MATERIALS AND METHODS: Archival histological material from 125 stage-II/III CRC patients was collected. Haematoxylin-and-eosin staining was performed to determine the tumour-stroma ratio (TSR), indicating stromal percentages in primary tumours, lymph nodes (LNs) and biopsies. On immunohistochemistry stains, FAP-expression was semiquantitatively scored as little-no, heterogeneous, or moderate-high expression. Correlation of TSR and FAP-expression with Chi-square testing was assessed. Other patterns were also described, e.g. tumour epithelial FAP-expression. RESULTS: In total, 93 patients (40 stage-III colon [CC], 53 stage-II/III RC) were included. Correlation between 41 (44 %) stroma-high CRC (18/40 CC, 45 %; 23/53 RC, 43 %) with high FAP-expression was not significant (P = 0.428 CRC; P = 0.470 CC; P = 0.615 RC). The majority of CRC had any FAP-expression (78 CRC, 84 %), mostly the invasive front, and in most associated LN metastases (87 % CRC tumour-positive LN). However, FAP-expression was often heterogeneous, even staining healthy colon and lymphoid tissue. CONCLUSIONS: CRCs and LN metastases generally express FAP, but levels vary significantly between and within tumours and have no direct correlation with TSR. Care has to be taken translating FAPI-PET/CT results with e.g. disease extent and activity, emphasizing the importance of multidisciplinary approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSerine EndopeptidasesGelatinasesMembrane ProteinsBiomarkers, TumorHumansFemaleMaleMiddle AgedAgedEndopeptidasesTumor MicroenvironmentCancer-Associated FibroblastsAdultAged, 80 and overNeoplasm StagingImmunohistochemistryFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

Cancer-associated fibroblastsColorectal cancerFibroblast activation proteinImmunohistochemistryTumor-stroma ratio

Substanzen

Serine EndopeptidasesGelatinasesMembrane ProteinsEndopeptidasesBiomarkers, TumorFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands; Department of Radiation Science & Technology, Delft…
  • Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: w.e.mesker@lumc.nl.

Zitieren

APA

Polack, M., van Pelt, G. W., Crobach, A. S. L. P., de Geus-Oei, L. F., Tollenaar, R. A. E. M., van Krieken, J. H. J. M., & Mesker, W. E. (2025). Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100964

Vancouver

Polack M, van Pelt GW, Crobach ASLP, de Geus-Oei LF, Tollenaar RAEM, van Krieken JHJM, et al. Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.100964

BibTeX
@article{Polack2025,
  author = {Polack, Meaghan and van Pelt, Gabi W and Crobach, Augustinus S L P and de Geus-Oei, Lioe-Fee and Tollenaar, Rob A E M and van Krieken, J Han J M and Mesker, Wilma E},
  title = {Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application},
  journal = {Cancer Treatment and Research Communications},
  year = {2025},
  doi = {10.1016/j.ctarc.2025.100964}
}
Kostenlos starten →